Happify Health Named to the 2020 CB Insights Digital Health 150 — List of Most Innovative Digital Health Startups
Happify Health recognized for achievements in Disease Management and Therapeutics
NEW YORK, August 13, 2020 — CB Insights today named digital therapeutics leader, Happify Health, to its second annual Digital Health 150 ranking, which showcases the 150 most promising private digital health companies in the world. Happify Health has been recognized for their achievements in the ranking’s Disease Management and Therapeutics category.
The 2020 Digital Health 150 cohort highlights startups that are reimagining the lines of the traditional healthcare experience across 12 categories, from Virtual Care Delivery and Clinical Trials, to Drug Discovery and Specialty Care. Countries represented this year include Canada, China, Israel, France, the United Kingdom, and the United States, among others.
“This year’s Digital Health 150 is our most global ever, covering the best private healthcare companies from 17 countries. Beyond geographic diversity, these companies are innovating across the entire healthcare value chain, spanning technologies that benefit pharma & biotech companies, to payers, hospitals, insurers, and more,” said CB Insights CEO Anand Sanwal. “Last year’s Digital Health 150 winners saw numerous exits and went on to raise nearly $5 billion in investor financing after being recognized. We look forward to seeing the success of this year's class of the best in digital health."
"In order to empower people to get to better healthcare and live their lives more fully, we believe that digital therapeutics will play an increasingly important role in enabling behavior change,” said Tomer Ben-Kiki, Co-Founder and CEO at Happify Health. “We are committed to addressing the challenges of quality, cost, and accessibility to create new care delivery models, and are honored to be named to the CB Insights Digital Health 150 ranking.”
Through an evidence-based approach, the CB Insights research team selected the Digital Health 150 from hundreds of applications based on several factors including patent activity, investor quality, news sentiment analysis, proprietary Mosaic score, market potential, partnerships, competitive landscape, team strength, and tech novelty. The Mosaic Score, based on CB Insights’ algorithm, measures the overall health and growth potential of private companies to help predict a company’s momentum.
Happify Health delivers safe, evidence-based therapeutic interventions to treat, manage or improve people’s physical or mental health through meaningful behavior change, enabling them to live fuller, happier lives. The company’s digital therapeutic platform addresses the symptoms of patients who suffer from stress, anxiety and depression and comorbid conditions exacerbated by these mental health disorders.
For people with chronic conditions, Happify Health develops both specialized prescription digital therapeutics that are FDA-cleared and prescribed by physicians as well as non-prescription core solutions, such as our newest care delivery platform, Kopa. Delivering on Happify Health's vision to provide end-to-end digital care delivery and a commitment to continuous innovation, the Kopa platform was designed with the complete patient in mind and has been purpose-built to meet both mental and physical health needs. With its first disease-specific product, Kopa for Psoriasis, patients are able to access expert advice, community support and personalized recommendations specific to their condition.
Quick facts on the 2020 Digital Health 150:
- The 2020 Digital Health 150 startups have raised over $20B in funding across 600+ deals from 900+ unique investors.
- The list includes 12 unicorns (companies that have reached a valuation of $1B+) focused on a diverse range of digital health solutions, including telehealth, insurance, and robotic surgical systems.
- Many have formed partnerships with key industry players like the American Heart Association, Cigna, and Mount Sinai Health System.
The Digital Health 150 Companies (in alphabetical order):
About CB Insights
At CB Insights, we believe the most complex strategic business questions are best answered with facts. We are a machine intelligence company that synthesizes, analyzes and visualizes millions of documents to give our clients fast, fact-based insights. Serving the majority of the Fortune 100, we give companies the power to make better decisions, take control of their own future, and capitalize on change.
Keith Swiader, Manager - PR & Communications
About Happify Health:
Happify Health is a LifeTech company that delivers digital therapeutics and innovative care delivery models to improve mental and physical health. As a leader in digital therapeutic solutions, Happify Health’s safe, effective digital tools use scientific research from positive psychology, CBT and mindfulness, combined with a gamified approach and leading-edge technology, to impact everyday lives. Happify Health's clinically-validated platform provides global access to one of the most comprehensive, evidence-based intervention catalog that is available from science, resulting in better health and business outcomes for organizations. For more information, visit www.happifyhealth.com
For press inquiries, contact:
Britta Franson, Director - PR & Communications, Happify Health